79 related articles for article (PubMed ID: 21818116)
21. Hypermethylation of SHP-1 promoter in patient with high-risk myelodysplastic syndrome and it predicts poor prognosis.
Zhang Y; Zhao D; Zhao H; Wu X; Zhao W; Wang Y; Xia B; Da W
Med Oncol; 2012 Dec; 29(4):2359-63. PubMed ID: 22258937
[TBL] [Abstract][Full Text] [Related]
22. Cell density dependent increase of constitutive signal transducers and activators of transcription 3 activity in melanoma cells is mediated by Janus kinases.
Kreis S; Munz GA; Haan S; Heinrich PC; Behrmann I
Mol Cancer Res; 2007 Dec; 5(12):1331-41. PubMed ID: 18171991
[TBL] [Abstract][Full Text] [Related]
23. Dihydroxypentamethoxyflavone down-regulates constitutive and inducible signal transducers and activators of transcription-3 through the induction of tyrosine phosphatase SHP-1.
Phromnoi K; Prasad S; Gupta SC; Kannappan R; Reuter S; Limtrakul P; Aggarwal BB
Mol Pharmacol; 2011 Nov; 80(5):889-99. PubMed ID: 21816954
[TBL] [Abstract][Full Text] [Related]
24. Knockdown of protein tyrosine phosphatase SHP-1 inhibits G1/S progression in prostate cancer cells through the regulation of components of the cell-cycle machinery.
Rodríguez-Ubreva FJ; Cariaga-Martinez AE; Cortés MA; Romero-De Pablos M; Ropero S; López-Ruiz P; Colás B
Oncogene; 2010 Jan; 29(3):345-55. PubMed ID: 19838216
[TBL] [Abstract][Full Text] [Related]
25. Role of the protein tyrosine phosphatase SHP-1 in Interleukin-6 regulation of prostate cancer cells.
Tassidis H; Culig Z; Wingren AG; Härkönen P
Prostate; 2010 Oct; 70(14):1491-500. PubMed ID: 20687222
[TBL] [Abstract][Full Text] [Related]
26. Dovitinib sensitizes hepatocellular carcinoma cells to TRAIL and tigatuzumab, a novel anti-DR5 antibody, through SHP-1-dependent inhibition of STAT3.
Chen KF; Chen HL; Liu CY; Tai WT; Ichikawa K; Chen PJ; Cheng AL
Biochem Pharmacol; 2012 Mar; 83(6):769-77. PubMed ID: 22230479
[TBL] [Abstract][Full Text] [Related]
27. BCL2 and JUNB abnormalities in primary cutaneous lymphomas.
Mao X; Orchard G; Lillington DM; Child FJ; Vonderheid EC; Nowell PC; Bagot M; Bensussan A; Russell-Jones R; Young BD; Whittaker SJ
Br J Dermatol; 2004 Sep; 151(3):546-56. PubMed ID: 15377339
[TBL] [Abstract][Full Text] [Related]
28. Boswellic acid blocks signal transducers and activators of transcription 3 signaling, proliferation, and survival of multiple myeloma via the protein tyrosine phosphatase SHP-1.
Kunnumakkara AB; Nair AS; Sung B; Pandey MK; Aggarwal BB
Mol Cancer Res; 2009 Jan; 7(1):118-28. PubMed ID: 19147543
[TBL] [Abstract][Full Text] [Related]
29. Promoter methylation attenuates SHP1 expression and function in patients with primary central nervous system lymphoma.
Liu J; Wang Y; Sun X; Ji N; Sun S; Wang Y; Liu F; Cui Q; Wang C; Liu Y
Oncol Rep; 2017 Feb; 37(2):887-894. PubMed ID: 27959415
[TBL] [Abstract][Full Text] [Related]
30. Screening for MPL mutations in essential thrombocythemia and primary myelofibrosis: normal Mpl expression and absence of constitutive STAT3 and STAT5 activation in MPLW515L-positive platelets.
Glembotsky AC; Korin L; Lev PR; Chazarreta CD; Marta RF; Molinas FC; Heller PG
Eur J Haematol; 2010 May; 84(5):398-405. PubMed ID: 20113333
[TBL] [Abstract][Full Text] [Related]
31. DNA methyltransferase 1 mediated aberrant methylation and silencing of SHP-1 gene in chronic myelogenous leukemia cells.
Li Y; Liu X; Guo X; Liu X; Luo J
Leuk Res; 2017 Jul; 58():9-13. PubMed ID: 28376405
[TBL] [Abstract][Full Text] [Related]
32. Trichostatin A, a histone deacetylase inhibitor, suppresses JAK2/STAT3 signaling via inducing the promoter-associated histone acetylation of SOCS1 and SOCS3 in human colorectal cancer cells.
Xiong H; Du W; Zhang YJ; Hong J; Su WY; Tang JT; Wang YC; Lu R; Fang JY
Mol Carcinog; 2012 Feb; 51(2):174-84. PubMed ID: 21520296
[TBL] [Abstract][Full Text] [Related]
33. Constitutive and specific activation of STAT3 by BCR-ABL in embryonic stem cells.
Coppo P; Dusanter-Fourt I; Millot G; Nogueira MM; Dugray A; Bonnet ML; Mitjavila-Garcia MT; Le Pesteur D; Guilhot F; Vainchenker W; Sainteny F; Turhan AG
Oncogene; 2003 Jun; 22(26):4102-10. PubMed ID: 12821944
[TBL] [Abstract][Full Text] [Related]
34. Constitutive STAT3 activation in peripheral CD3(+) cells from patients with primary Sjögren's syndrome.
Ramos HL; Valencia-Pacheco G; Alcocer-Varela J
Scand J Rheumatol; 2008; 37(1):35-9. PubMed ID: 18189193
[TBL] [Abstract][Full Text] [Related]
35. IL-6 production is positively regulated by two distinct Src homology domain 2-containing tyrosine phosphatase-1 (SHP-1)-dependent CCAAT/enhancer-binding protein β and NF-κB pathways and an SHP-1-independent NF-κB pathway in lipopolysaccharide-stimulated bone marrow-derived macrophages.
Rego D; Kumar A; Nilchi L; Wright K; Huang S; Kozlowski M
J Immunol; 2011 May; 186(9):5443-56. PubMed ID: 21422245
[TBL] [Abstract][Full Text] [Related]
36. Contribution of STAT3 to the activation of survivin by GM-CSF in CD34+ cell lines.
Gu L; Chiang KY; Zhu N; Findley HW; Zhou M
Exp Hematol; 2007 Jun; 35(6):957-66. PubMed ID: 17533050
[TBL] [Abstract][Full Text] [Related]
37. The SHP-1 expression is associated with cytokines and psychopathological status in unmedicated first episode schizophrenia patients.
Pesce M; Ferrone A; Rizzuto A; Tatangelo R; Iezzi I; Ladu S; Franceschelli S; Speranza L; Patruno A; Felaco M; Grilli A
Brain Behav Immun; 2014 Oct; 41():251-60. PubMed ID: 24793756
[TBL] [Abstract][Full Text] [Related]
38. Alteration of SHP-1/p-STAT3 Signaling: A Potential Target for Anticancer Therapy.
Huang TT; Su JC; Liu CY; Shiau CW; Chen KF
Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28594363
[TBL] [Abstract][Full Text] [Related]
39. Increased promoter methylation of the immune regulatory gene SHP-1 in leukocytes of multiple sclerosis subjects.
Kumagai C; Kalman B; Middleton FA; Vyshkina T; Massa PT
J Neuroimmunol; 2012 May; 246(1-2):51-7. PubMed ID: 22458980
[TBL] [Abstract][Full Text] [Related]
40. Cucurbitacin I inhibits Stat3 and induces apoptosis in Sézary cells.
van Kester MS; Out-Luiting JJ; von dem Borne PA; Willemze R; Tensen CP; Vermeer MH
J Invest Dermatol; 2008 Jul; 128(7):1691-5. PubMed ID: 18200050
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
